U.S. Beverage Stock News

AAON has reported that its Alpha Class EXTREME SERIES rooftop HVAC unit exceeded U.S. Department of Energy challenge standards. The unit delivered true simultaneous dual fuel operation while maintaining efficient performance at temperatures below typical industry requirements. The product is aimed at commercial buildings where retrofit friendly, high performance heating and cooling solutions are in demand. For investors watching NasdaqGS:AAON, this product news adds a fresh data point...

Marriott Vacations Worldwide (NYSE:VAC) recorded about $546 million in non-cash impairments tied to asset write downs and goodwill linked to earlier acquisitions. The company is reshaping its priorities toward profitability and free cash flow, including deferred or cancelled projects in Asia and fewer Asia Pacific tours planned for 2026. Leadership changes include Matt Avril stepping in as CEO and Mike Flaskey as President, signaling a new direction for the vacation ownership business. For...

If you are wondering whether Sonic Automotive's current share price gives you genuine value, it helps to break the story into what the stock has done recently and what the fundamentals say about it. The shares most recently closed at US$62.62, with returns of 4.4% over 30 days, 1.6% year to date, a 3.2% decline over 1 year, 13.5% over 3 years and 38.0% over 5 years. Recent coverage around Sonic Automotive has focused on its position as a US auto retailer and how investors are weighing that...

Versant Media Group (NasdaqGS:VSNT) authorized a new $1b share repurchase program. The company declared a quarterly cash dividend, initiating regular capital returns to shareholders. Management highlighted recent acquisitions and progress in building Versant as a standalone public company. Versant Media Group, trading at $34.01 per share, is moving ahead with a mix of buybacks, dividends, and acquisitions that directly affect how capital is used. The stock is up 13.9% over the past week and...

Vir Biotechnology (VIR) is back in focus after its agreement with Astellas Pharma on prostate cancer candidate VIR-5500, along with fresh Phase 1 data and several recent equity financing moves. See our latest analysis for Vir Biotechnology. Despite a 4.6% 1-day share price decline to US$8.91 and some pressure over the past week, Vir Biotechnology’s roughly 20% 1-month and 42% 3-month share price returns suggest momentum has picked up around the Astellas partnership, Phase 1 VIR-5500 data and...

Core Scientific (CORZ) just posted its FY 2025 Q4 numbers, reporting revenue of US$79.8 million, basic EPS of US$0.68 and net income of US$216.0 million. The company has seen quarterly revenue move in a tight band between US$78.6 million and US$95.4 million since late 2024, while basic EPS has swung from a loss of US$1.17 per share in 2024 Q3 to a profit of US$0.68 in 2025 Q4, highlighting how volatile margins have been for shareholders tracking the story. With trailing twelve month EPS still...

Wondering whether Stoke Therapeutics at around US$33.78 is starting to look expensive or if there is still value on the table? This article walks through the key numbers so you can judge for yourself. The stock has been volatile, with a 4.8% decline over the last 7 days, an 11.3% gain over 30 days, a 9.3% return year to date, a 345.6% return over 1 year, a 266.0% return over 3 years, and a 34.9% decline over 5 years. These price swings sit against a backdrop of ongoing attention on Stoke...

CACI International (NYSE:CACI) has announced and priced a $500 million senior notes offering. The company plans to use the proceeds to help fund its acquisition of ARKA Group L.P. The transaction affects CACI International's capital structure and future debt obligations. For investors watching NYSE:CACI, this new senior notes offering comes at a time when the stock is trading at $629.75. The shares show longer term returns of 78.4% over the past year, 110.5% over three years, and 182.1%...

The Morning Bull - US Market Morning Update Wednesday, Mar, 4 2026 US stock futures are slightly softer this morning, with E-mini S&P 500 contracts down about 0.2%, as investors juggle stubborn inflation worries and mixed global growth signals. The US 10 year Treasury yield is holding near 4.06%, which indicates borrowing costs remain relatively high and keeps pressure on areas like real estate and smaller, debt heavy companies. At the same time, a large 5.6 million barrel build in US oil...

GXO Logistics (NYSE:GXO) has entered a new partnership with lingerie retailer Hunkemoller to manage its B2B logistics. The agreement covers operations at a state of the art facility in Almere and is structured as a multi year deal. This is Hunkemoller’s first time outsourcing its B2B logistics operations to an external provider. For you as an investor, this move highlights how GXO Logistics (NYSE:GXO) positions itself as a specialist in complex, tech driven logistics for retailers. The...

NextDecade (NasdaqCM:NEXT) approved positive final investment decisions on Trains 4 and 5 at its Rio Grande LNG Facility. The company executed multiple long term LNG sale and purchase agreements tied to these additional trains. These steps expand NextDecade's planned LNG production capacity and build out its contracted commercial portfolio. NextDecade focuses on developing LNG export capacity at its Rio Grande LNG Facility, positioning itself as a US Gulf Coast supplier to global buyers...

Rumors are circulating that Sanofi is considering a significantly higher acquisition bid for Ocular Therapeutix (NasdaqGM:OCUL). The speculation follows recent regulatory developments that may create new or faster FDA approval routes for the company’s ophthalmology programs. Market attention has increased as investors assess what a larger potential offer and altered commercialization timelines could mean for OCUL’s valuation and future role in eye care. Ocular Therapeutix focuses on...

CBIZ (NYSE:CBZ) reported weak underlying organic growth, while headline revenue gains were largely driven by acquisitions. Management flagged that some mid market client projects were postponed and issued a modest growth outlook for 2026. The update points to softer demand from key mid market clients and a greater reliance on acquired revenue. For investors watching NYSE:CBZ, the latest update comes after a sharp share price reset, with the stock down 24.1% over the past month and 41.2%...

NCR Voyix (NYSE: VYX) has secured 7-Eleven Philippines as a major new client. The agreement covers technology upgrades across more than 4,500 convenience stores. The engagement combines software platforms and professional services to support a broad retail technology refresh. NCR Voyix is adding this large 7-Eleven Philippines win at a time when the stock has faced pressure, with NYSE: VYX showing a 25.8% decline over the past year and a 63.7% decline over the past five years. At a recent...

If you are wondering whether SmartStop Self Storage REIT is attractively priced or starting to look expensive, this article will walk through what the current numbers actually say about its value. The stock most recently closed at US$32.49, with a 3.3% return over the last 30 days and a 5.6% return year to date, while the last 7 days show a 2.6% decline. Recent coverage around SmartStop has focused on its position in the self storage sector and how it is responding to investor interest in...

Helios Technologies (HLIO) closed out FY 2025 with fourth quarter revenue of US$210.7 million and basic EPS of US$0.59, alongside trailing twelve month EPS of US$1.46 and revenue of US$839 million that came with 24.5% earnings growth and higher net profit margins year on year. Over the last few quarters, the company has reported revenue between US$195.5 million and US$220.3 million per quarter, with basic EPS ranging from US$0.22 to US$0.59. This sets up a picture of earnings that are growing...

If you are wondering whether Everest Group's current share price offers good value or not, the key is to understand how it stacks up against a few different valuation yardsticks. The stock most recently closed at US$335.13, with returns of 1.2% over 30 days, a small 0.2% gain year to date, and a 3.4% decline over the past year, which may signal shifting views on its potential and risk. Recent news coverage has mainly focused on Everest Group's position in the broader insurance and...

Globe Life (NYSE:GL) announced an increase in its quarterly dividend, approved by the Board of Directors. Executive Vice President and Chief Strategy Officer Michael Clay Majors reported a significant sale of Globe Life shares. The combination of a higher dividend and sizable insider selling is drawing attention to management signals and capital allocation. Globe Life, trading at $144.69 at the last close, has seen its share price rise 1.7% over the past week, 3.2% over the past month, and...

Innovex International (INVX) has moved back into focus after existing shareholders completed a US$148.1 million follow on equity offering of 5,750,000 common shares at US$25.75 each, alongside a planned share repurchase. See our latest analysis for Innovex International. The follow-on sale at US$25.75 has come alongside a period of mixed short-term trading, with a 1-day share price return of a 3.05% decline and a 7-day share price return of an 11% decline. However, the 30-day and year-to-date...

Investors wondering if Clear Channel Outdoor Holdings at around US$2.39 is still offering value, or if the easy gains are already behind it, can use this article to unpack what the current price really implies. The stock has posted returns of 0.8% over the last 7 days, 14.4% over 30 days, 12.7% year to date, 83.8% over 1 year and 60.4% over 3 years. These figures put recent moves and risk perceptions firmly in focus. Recent headlines around Clear Channel Outdoor Holdings have been less about...

Ardelyx (NasdaqGM:ARDX) announced a multi year partnership with the LPGA focused on advancing women's digestive health initiatives. The collaboration is designed to combine Ardelyx's gastrointestinal expertise with the LPGA's global platform to expand outreach and education. The partnership aims to reach female athletes and fans with programs that highlight digestive health awareness and patient engagement. For investors watching NasdaqGM:ARDX, this announcement comes with the stock at a...

Recently, Healthcare Services Group reported strong fourth-quarter results with better-than-expected adjusted EBITDA, prompting RBC Capital to begin coverage and other analysts to reiterate their positive views on the company’s fundamentals. The latest analyst commentary highlights how improving skilled nursing facility economics and growing emphasis on clinical quality may support rising demand for Healthcare Services Group’s outsourced environmental and dietary services across U.S. care...

How Surgery Partners' FY 2025 Numbers Set Up the Next Phase of Its Story Surgery Partners (SGRY) has closed out FY 2025 with fourth quarter revenue of US$885 million and a basic EPS loss of US$0.12, alongside a full year trailing revenue base of about US$3.3 billion and a trailing EPS loss of US$0.61. The company has seen quarterly revenue move from US$770.4 million in Q3 2024 to US$821.5 million in Q3 2025 and US$885 million in Q4 2025. Over the same period, quarterly EPS moved from a loss...

Acadia Healthcare Company (NasdaqGS:ACHC) recorded a substantial non cash goodwill impairment charge in Q4 2025. The impairment led to a significant net loss for both the quarter and the full year 2025. Operational growth continued through facility expansions and new joint ventures despite the non recurring charge. For investors watching Acadia Healthcare at a share price of $22.99, the goodwill impairment is a key development to factor into any assessment of the business. The stock has...